- Big Health Care Disparities Persist Across the U.S., New Report Finds
- Teens Often Bullied Online About Their Weight: Study
- Work That Challenges Your Brain Helps You Stay Sharp With Age
- Urine Test Might Spot Head-and-Neck Cancers Early
- Many Seniors Are Overmedicated, But ChatGPT Might Prevent That
- Antipsychotics May Do Great Harm to People With Dementia: Report
- Two-Drug Combo Curbs Drinking for People Battling Severe Alcoholism
- Most Homeless Americans Are Battling Mental Illness
- FDA Recalls Heart Failure Devices Linked to Injuries and Deaths
- COVID Does Not Spur Asthma in Kids, Study Finds
Health Highlights: June 16, 2017
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:
New EpiPen Competitor Approved by FDA
A new competitor for EpiPen has been approved by the U.S. Food and Drug Administration.
The emergency injection device to treat life-threatening allergic reactions is called Symjepi and is made by Adamis Pharmaceuticals Corp., the Associated Press reported.
Symjepi is meant to be a “low-cost alternative” to EpiPen and similar products, and Adamis wants to sell it for less than generic EpiPens, according to company spokesman Mark Flather.
EpiPens have soared in price in recent years, prompting concern from doctors and patients alike.
An exact price has not been set for Symjepi, which will be sold in pairs like EpiPen, the AP reported.
Copyright © 2024 HealthDay. All rights reserved.
Related
-
Birth Control Pill Might Lower Odds for Sports InjuriesActive women using the pill appear to receive an...
- April 17, 2024
-
Good Blood Pressure Control Could Prevent FibroidsKeeping blood pressure under control could be crucial for...
- April 16, 2024
-
One in 3 Women With Migraines Say Attacks Occur During PeriodsAmong U.S. women with migraine, a third say the...
- April 15, 2024
-
Big Rise in Young Adults Undergoing Permanent Sterilization After Dobbs DecisionAn increasing number of young men and women have...
- April 12, 2024
